EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Peri‐Conception Human Papillomavirus Vaccination Exposure and Risk of Birth Defects: A Population‐Based Retrospective Cohort Study

Jin Guo, Peng Zhao, Chunrong Liu, Mingyu Liao, Jingwen Chen, Yan Ren, Guanhua Yao, Yongyao Qian, Biao Rong, Huanyang Qi, Moliang Chen, Kang Zou und 3 weitere

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70222 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Jin Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Congenital Abnormalities, Papillomavirus Infections, Papillomavirus Vaccines, Vaccination. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Women of childbearing age may receive human papillomavirus (HPV) vaccination during pregnancy, yet evidence on birth defects (BDs) risks remains limited. This study evaluates associations between peri‐conception (from 30 days before the last menstrual period and the end of the first trimester) HPV vaccination and BDs.

Methods

This population‐based retrospective cohort study included pregnancies with last menstrual periods between March 2018 and March 2021 in Xiamen, China. Propensity score matching (PSM) based Poisson regression with robust variance estimation was used to estimate the adjusted relative risk ( aRR ) of exposure for total BDs and 10 organ system‐specific BDs . Subgroup analysis (Different vaccine valences) and eight sensitivity analyses were performed.

Results

A total of 177,574 pregnancies were included, of which 300 were exposed to the HPV vaccine during the peri‐conception period. The rate of peri‐conception vaccine exposure increased from 0.07% in 2018 to 0.34% in 2021. After 1:4 PSM , peri‐conception HPV vaccination was not associated with an increased risk of total BDs ( aRR 0.66, 95% confidence interval [ CI ] 0.26–1.70). Similarly, no significant association was found between HPV vaccination and the organ system‐specific BDs . Subgroup analysis showed exposure to the 4vHPV ( aRR 0.99, 95% CI 0.34–2.94) and 9vHPV ( aRR 0.98, 95% CI 0.11–8.69) vaccines were also not associated with a higher risk of total BDs . All sensitivity analyses, including negative control, demonstrated the robustness of the results.

Conclusion

This study suggests that exposure to the HPV vaccine during the peri‐conception period does not increase the risk of BDs . However, the precision of organ system‐specific BDs remains limited, necessitating validation through larger‐scale studies. Trial Registration This study was registered at ClinicalTrials.gov (NCT06180447)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital AbnormalitiesPapillomavirus InfectionsPapillomavirus VaccinesVaccinationAdultFemaleHumansPregnancyYoung AdultChinaHuman Papillomavirus VirusesRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

HPV vaccinebirth defectsperi‐conceptionpopulation‐based cohortpregnancy

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • General Practice Medical Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
  • NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu, China.
  • Sichuan Center of Technology Innovation for Real World Data, Chengdu, China.
  • Xiamen Health Commission, Xiamen, China.
  • Xiamen Health and Medical Big Data Center, Xiamen, China.

ORCID-Profile: Xin Sun

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • National Key Research and Development Program of China
  • National Science Fund for Distinguished Young Scholars
  • 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
  • Xiamen Science and Technology Plan Project

Zitieren

APA

Guo, J., Zhao, P., Liu, C., Liao, M., Chen, J., Ren, Y., Yao, G., Qian, Y., Rong, B., Qi, H., Chen, M., Zou, K., Xiong, Y., Sun, X., & Tan, J. (2025). Peri‐Conception Human Papillomavirus Vaccination Exposure and Risk of Birth Defects: A Population‐Based Retrospective Cohort Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70222

Vancouver

Guo J, Zhao P, Liu C, Liao M, Chen J, Ren Y, et al. Peri‐Conception Human Papillomavirus Vaccination Exposure and Risk of Birth Defects: A Population‐Based Retrospective Cohort Study. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70222

BibTeX
@article{Guo2025,
  author = {Guo, Jin and Zhao, Peng and Liu, Chunrong and Liao, Mingyu and Chen, Jingwen and Ren, Yan and Yao, Guanhua and Qian, Yongyao and Rong, Biao and Qi, Huanyang and Chen, Moliang and Zou, Kang and Xiong, Yiquan and Sun, Xin and Tan, Jing},
  title = {Peri‐Conception Human Papillomavirus Vaccination Exposure and Risk of Birth Defects: A Population‐Based Retrospective Cohort Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70222}
}
Kostenlos starten →